Genoil (GNOLF) Change in Accured Expenses (2009 - 2025)

Genoil (GNOLF) has 10 years of Change in Accured Expenses data on file, last reported at $10251.0 in Q4 2025.

• On a quarterly basis, Change in Accured Expenses rose 26.32% year-over-year to $10251.0 in Q4 2025; TTM through Dec 2025 was $33644.0, a 19.28% increase from a year earlier, with the FY2025 full-year figure at $33644.0, up 19.28% from the prior year.
• Change in Accured Expenses for Q4 2025 stood at $10251.0, up from $8115.0 in the prior quarter.
• Over the last five years, Change in Accured Expenses for GNOLF reached as high as $877067.0 in Q4 2022 and fell as low as $3945.0 in Q3 2022.
• Historically, Change in Accured Expenses has averaged $169430.0 across 5 years, with a median of $9183.0 in 2024.
• Across the five-year window, Change in Accured Expenses soared 2392.52% in 2021 and tumbled 99.26% in 2023, its largest moves.
• Year by year, Change in Accured Expenses stood at $429885.0 in 2021, then surged by 104.02% to $877067.0 in 2022, then tumbled by 99.26% to $6461.0 in 2023, then increased by 25.6% to $8115.0 in 2024, then advanced by 26.32% to $10251.0 in 2025.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $10251.0 in Q4 2025, $8115.0 in Q3 2025, and $7792.0 in Q2 2025.